The efficacy of an abbreviated model of the International Prostate Symptom Score in evaluating benign prostatic hyperplasia

BJU International

Volumn 91, Issue 3, 2003, Pages 186-189

  Cam, K ^a   Senel, F ^a   Akman, Y ^a   Erol, A ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Benign prostatic hyperplasia; Diagnosis; Evaluation; IPSS; Symptom score

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEVELOPING COUNTRY; EDUCATION; EVALUATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PHYSICIAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF EVALUATION; SYMPTOM; TURKEY (REPUBLIC); URETHRA;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; EDUCATIONAL STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; TURKEY;

EID: 0037326485     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04055.x     Document Type: Article

References (16)

1. Bruskewitz R. Management of symptomatic BPH in the USA. Who is treated and how? Eur Urol 1999; 36 (Suppl. 3): 7-13
2. Roehrborn CG. The newly established guidelines for the diagnosis and management of benign prostatic hyperplasia. Curr Opinion Urol 1995; 5: 30-5
3. Mebust WK, Holtgrewe HL, Cockett ATK, Peter PC and the Writing Committee. Transurethral prostatectomy. Immediate and postoperative complications. A cooperative study of thirteen participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243-53
4. McConnell JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In Walsh PC, Retik AB, Vaughan ED, Wein AF eds, Campbell's Urology. 7th edn, Vol. II. Chapt. 46. Philadelphia: WB Saunders, 1998: 1429-52
5. Netto NR Jr, de Lima ML, de Andrade EF et al. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia. Urology 1997; 49: 46-4
6. Lujan Galan M, Paez Borda A, Martin Oses E, Llanes Gonzalez L, Berenguer Sanchez A. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch Esp Urol 1997; 50: 847-53
7. Cockett ATK. Editorial comment: Symptom score in patients with benign prostatic hyperplasia. J Urol 1996; 155: 1959
8. Plante M, Corcos J, Gregorie I, Belanger MF, Brock G, Rossingol M. The International Prostate Symptom Score: physician versus self-administration in the quantification of symptomatology. Urology 1996; 47: 326-8
9. Netto NR Jr, de Lima ML. The influence of patient education level on the international prostatic symptom score. J Urol 1995; 154: 97-9
10. Barry MJ, Fowler FJ, O'Leary MP et al. and the Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
11. Russo F, Di Pasquale B, Romano G et al. International prostate symptom score: comparison of doctor and patient. Arch Ital Urol Androl 1998; 70 (Suppl 3): 15-24
12. MacDiarmid SA, Goodson TC, Holmes TM, Martin PR, Doyle RB. An assessment of the comprehension of the American Urological Association Symptom Index. J Urol 1998; 159: 873-4
13. Van Schaik P, Ahmed T, Suvakovic N, Hindmarsh JR. Effect of an educational multimedia prostate program on the International Prostate Symptom Score. Eur Urol 1999; 36: 36-9
14. Sagnier PP, Girman CJ, Garraway M et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 9: 15-20
15. Jepsen JV, Bruskewitz RC. Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998; 51 (Suppl. 4A): 13-8
16. Jepsen JV, Bruskewitz RC. Office evaluation of men with lower urinary tract symptoms. Urol Clin North Am 1998; 25: 545-54